Results 231 to 240 of about 562,936 (248)

Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.

Current Medicinal Chemistry, 2008
J. Ashton, J. Wright, J. McPartland, J. Tyndall   +3 more
semanticscholar   +1 more source

Interactions between the CB1 receptor agonist Δ9-THC and the CB1 receptor antagonist SR-141716 in rats

Pharmacology Biochemistry and Behavior, 2002
Torbjörn U.C. Järbe, Matthew E. Andrzejewski, Nicholas V. DiPatrizio   +2 more
openaire   +1 more source

Pyridine-3-carboxamide derivatives as CB1 inverse agonists

2006
HEBEISEN PAUL, IDING HANS, NETTEKOVEN MATTHIAS HEINRICH, OBST ULRIKE, ROEVER STEPHAN, WIRZ BEAT   +5 more
openaire   +2 more sources

CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat

Psychopharmacology, 2005
S. Vlachou, G. Nomikos, G. Panagis
semanticscholar   +1 more source

Can dronabinol, a CB1 agonist, suppress opioid withdrawal in humans?

Drug and Alcohol Dependence, 2015
Michelle R. Lofwall, Shanna Babalonis, Claude Elayi, Paul A. Nuzzo, Kathryn E. Gill, Sharon L. Walsh   +5 more
openaire   +1 more source

Design, synthesis, and structure–activity relationship study of conformationally constrained analogs of indole-3-carboxamides as novel CB1 cannabinoid receptor agonists

Bioorganic and Medicinal Chemistry Letters, 2010
Mark York, Glenn Walker, Takao Kiyoi
exaly  

Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat

Synapse, 2003
C. Verrico, J. Jentsch, L. Dazzi, R. H. Roth   +3 more
semanticscholar   +1 more source

Tetrahydroindazole derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonists

Bioorganic and Medicinal Chemistry Letters, 2016
Mark Macielag
exaly  

2-AMINOBENZOTHIAZOLES AS CB1 RECEPTOR INVERSE AGONISTS

2005
NETTEKOVEN MATTHIAS HEINRICH, ROEVER STEPHAN   +1 more
openaire   +2 more sources

Tetrahydropyrazolo[4,3-c]pyridine derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonists

Bioorganic and Medicinal Chemistry Letters, 2016
Mark Macielag
exaly